Critical Care Medicine (journal)

From WikiMD's WELLNESSPEDIA

Critical Care Medicine is a peer-reviewed monthly medical journal covering all aspects of critical care medicine. It was established in 1973 and is published by the Society of Critical Care Medicine. The editor-in-chief is Timothy G. Buchman (Emory University School of Medicine).

History[edit]

The journal was established in 1973 by the Society of Critical Care Medicine. It was initially published quarterly, but due to its increasing popularity and the growing field of critical care medicine, it became a monthly publication in 1977.

Scope[edit]

The journal publishes articles on all aspects of acute and emergency care for the critically ill or injured patient. This includes original research, review articles, and case reports. The journal also publishes guidelines and consensus statements from the Society of Critical Care Medicine and other professional organizations.

Abstracting and indexing[edit]

The journal is abstracted and indexed in PubMed, Scopus, and the Science Citation Index. According to the Journal Citation Reports, the journal has a 2019 impact factor of 6.312.

Editorial board[edit]

The current editor-in-chief is Timothy G. Buchman, who is affiliated with the Emory University School of Medicine. The editorial board consists of experts in the field of critical care medicine from around the world.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.